An important point to note is that diagnosing ALK-negative IMT is challenging due to its markedly variable histomorphology, the absence of a definitive immunoprofile, and a long list of differential diagnoses related to the tumor's location [40]. This evidence concerns the gene ALK and inflammatory myofibroblastic tumor.